Guttman-Yassky, E.; Blauvelt, A.; Eichenfield, L.; Paller, A.; Armstrong, A.; Drew, J.; Gopalan, R.; Simpson, E. Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements. J of Skin 2020, 4, s94.